Evidence map›Paper›PMID 35564141›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Analysis of the In Vitro Toxicity of Nanocelluloses in Human Lung Cells as Compared to Multi-Walled Carbon Nanotubes.

Fátima Pinto, Ana Filipa Lourenço, Jorge F S Pedrosa, Lídia Gonçalves, Célia Ventura, Nádia Vital, Ana Bettencourt, Susete N Fernandes, Rafaela R da Rosa, Maria Helena Godinho and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Genotoxicity of nanoparticles evaluated using theJournal of environmental science and health. Part C, Toxicology and carcinogenesis · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Fátima PintoNational Institute of Health Doutor Ricardo Jorge, Department of Human Genetics, 1649-016 Lisbon, Portugal.ORCID 0000-0002-9377-4085
Ana Filipa LourençoRAIZ-Forest and Paper Research Institute, 3800-783 Eixo, Portugal.
Jorge F S PedrosaCIEPQPF, Department of Chemical Engineering, University of Coimbra, Pólo II, 3030-790 Coimbra, Portugal.ORCID 0000-0002-6900-1592
Lídia GonçalvesResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.ORCID 0000-0002-6799-2740
Célia VenturaNational Institute of Health Doutor Ricardo Jorge, Department of Human Genetics, 1649-016 Lisbon, Portugal.ORCID 0000-0002-0637-2222
Nádia VitalNational Institute of Health Doutor Ricardo Jorge, Department of Human Genetics, 1649-016 Lisbon, Portugal.
Ana BettencourtResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.ORCID 0000-0002-8498-5892
Susete N FernandesCENIMAT/I3N, Department of Materials Science, NOVA School of Science and Technology (FCT NOVA), NOVA University Lisbon, Campus da Caparica, 2825-149 Caparica, Portugal.ORCID 0000-0002-7871-6717
Rafaela R da RosaCENIMAT/I3N, Department of Materials Science, NOVA School of Science and Technology (FCT NOVA), NOVA University Lisbon, Campus da Caparica, 2825-149 Caparica, Portugal.
Maria Helena GodinhoCENIMAT/I3N, Department of Materials Science, NOVA School of Science and Technology (FCT NOVA), NOVA University Lisbon, Campus da Caparica, 2825-149 Caparica, Portugal.ORCID 0000-0002-9760-5983
Henriqueta LouroNational Institute of Health Doutor Ricardo Jorge, Department of Human Genetics, 1649-016 Lisbon, Portugal.ORCID 0000-0001-9744-7332
Paulo J T FerreiraCIEPQPF, Department of Chemical Engineering, University of Coimbra, Pólo II, 3030-790 Coimbra, Portugal.ORCID 0000-0002-4503-6811
Maria João SilvaNational Institute of Health Doutor Ricardo Jorge, Department of Human Genetics, 1649-016 Lisbon, Portugal.ORCID 0000-0002-6060-0716
National Institute of Health Dr. Ricardo Jorge · PTUniversidade Nova de Lisboa · PTUniversity of Coimbra · PTUniversity of Lisbon · PT

Funding

Ministry of Science Technology and Higher Education PTDC/SAU-PUB/32587/2017
6 · The paper itself

Abstract

Cellulose micro/nanomaterials (CMNM), comprising cellulose microfibrils (CMF), nanofibrils (CNF), and nanocrystals (CNC), are being recognized as promising bio-nanomaterials due to their natural and renewable source, attractive properties, and potential for applications with industrial and economical value. Thus, it is crucial to investigate their potential toxicity before starting their production at a larger scale. The present study aimed at evaluating the cell internalization and in vitro cytotoxicity and genotoxicity of CMNM as compared to two multi-walled carbon nanotubes (MWCNT), NM-401 and NM-402, in A549 cells. The exposure to all studied NM, with the exception of CNC, resulted in evident cellular uptake, as analyzed by transmission electron microscopy. However, none of the CMNM induced cytotoxic effects, in contrast to the cytotoxicity observed for the MWCNT. Furthermore, no genotoxicity was observed for CNF, CNC, and NM-402 (cytokinesis-block micronucleus assay), while CMF and NM-401 were able to significantly raise micronucleus frequency. Only NM-402 was able to induce ROS formation, although it did not induce micronuclei. Thus, it is unlikely that the observed CMF and NM-401 genotoxicity is mediated by oxidative DNA damage. More studies targeting other genotoxicity endpoints and cellular and molecular events are underway to allow for a more comprehensive safety assessment of these nanocelluloses.

Indexed as

cell uptakegenotoxicityin vitro cytotoxicitymicro/nanocellulosesmicronucleus assayreactive oxygen species

Identifiers

PMID35564141
PMCPMC9104944
OpenAlexW4224317510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.